Brief: Regenxbio Q4 License & Royalty Revenue USD 27.148 Million
05/03/2026 12:05
Mar 05 (Reuters) - Regenxbio Q4 net income USD -67.149 million. Q4 operating expenses USD 87.973 million
- $541.79m
- $568.63m
- $170.44m
Mar 05 (Reuters) - Regenxbio Q4 net income USD -67.149 million. Q4 operating expenses USD 87.973 million